Florida Southern College Digital Repository

Generation of Controlled Release Gelatin-NSAID Conjugates for Post-Surgical Applications

Show simple item record

dc.contributor.advisor Shameka Shelby, Ph.D.
dc.contributor.author Rozen, Emily
dc.date.accessioned 2021-05-07T01:04:55Z
dc.date.available 2021-05-07T01:04:55Z
dc.date.issued 2021-05
dc.identifier.uri http://hdl.handle.net/11416/559
dc.description Honors Thesis Spring 2021 en_US
dc.description.abstract Nonsteroidal anti-inflammatory drugs (NSAIDs) are often prescribed after surgery to reduce inflammation and aid in pain management. NSAIDs, such as Advil, Motrin, and Aleve, are typically taken orally as over-the-counter medication. While these drugs are typically safe in small doses, sustained intake of high doses can have adverse side effects. The goal of this project was to design a product that would allow for direct application of NSAIDs to the surgical site, avoiding systemic circulation. By conjugating the NSAID to a gelatin hemostatic agent, the product can be applied to the open site and provide a subcutaneous delayed release. Type B gelatin was conjugated to the NSAID diclofenac using 1-ethyl-3-(-3-dimethylaminopropyl) carbodiimide (EDC) as the cross-linking agent. UV-Vis spectrometry confirmed concentrations eluted across different time frames to confirm the presence of a controlled release system. Use of this new technology in post-operative scenarios may help to lower NSAID intake, efficiently aid in patient pain management, and improve surgical protocols. en_US
dc.publisher Florida Southern College en_US
dc.subject Nonsteroidal anti-inflammatory agents en_US
dc.subject Drugs -- Side effects en_US
dc.subject Surgery, Operative en_US
dc.title Generation of Controlled Release Gelatin-NSAID Conjugates for Post-Surgical Applications en_US
dc.type Thesis en_US

Files in this item

This item appears in the following Collection(s)

Show simple item record



My Account